The #1 Event for Rejuvenation Biotechnology and Life Extension
We at Lifespan.io are excited to announce our fourth annual Ending Age-Related Diseases Conference, EARD2021. The conference will take place virtually on August 19-22, 2021 and will focus on four traditional themes: the mechanisms of aging, rejuvenation human trials, biomarkers of aging, and investment matters.
We will be looking at the longevity industry as an ecosystem, trying to identify the gaps in coordination and collaboration that can be filled by a concerted effort of the community.
Registration is open, and early bird tickets are available until June 30, 2021, so don’t delay, get your tickets today!
Come and see the leading experts in aging and rejuvenation research
You can expect to see keynotes delivered by top industry experts, interactive panels and interviews by community leaders, and thought-provoking scientific sessions. Special attention will be focused on the burden of neurodegenerative diseases and innovative approaches to maintaining and restoring mental health.
We are excited to confirm that Eric Verdin, João Pedro de Magalhães, Aubrey de Grey, Irina Conboy, and Vadim Gladyshev will be speaking at the conference, and we will be announcing many more!
How will you benefit from attending the conference?
Whether you are a researcher, longevity supporter, medical services provider, head of a rejuvenation biotechnology company, or investor, this conference will provide you with cutting-edge information and the opportunity to network with like-minded individuals.
EARD2021 offers you the opportunity to learn what is going on in other labs working in the rejuvenation biotechnology space and discuss promising directions and potential blind spots with your peers. Q&A sections, breakout rooms, instant messages, forums and 1-1 video calls will allow you to network and exchange ideas with other researchers in the comfort of your room. If you wish to give a talk but the main program is full, you are welcome to participate in the Lifespan Factory, an area of the event site filled with on-demand talks that the participants can watch at their own pace. Let us know if you are interested!
The conference will let you get the latest life extension and rejuvenation information directly from researchers, sometimes even before it is published! If you want to know the latest news about longevity research direct from the labs, then don’t miss the opportunity to join us at this action-packed event. You will hear about the latest innovations happening in the lab right now and learn more about the rejuvenation therapies being developed that could help you to enjoy healthy longevity. On top of that, being among like-minded people and exchanging insights is refreshing!
EARD2021 will feature the leading researchers and biotech companies working on rejuvenation and longevity, and thanks to the networking features offered by our virtual platform, scouting will be a breeze. This year, we are dedicating an entire day to discussing investment issues so that you can consider new approaches to risk management and new ways to collaborate with other investors on biotech projects that have the potential to change the world. If you wish to participate in a talk but the main program is full, you are welcome to participate in the Lifespan Factory – a series of on-demand talks that conference participants can watch at their own pace. Let us know if you are interested!
The conference is a great space to discuss your company and the rejuvenation therapy that you are developing or already marketing. If you have new research data to present, you are welcome to apply as a speaker, and we also offer a range of sponsorship opportunities. At our conference, you can find both new partners and new customers. We’ll do our best to make your company more visible to the longevity community during and after the event.
With so many treatments targeting aging in human clinical trials, and aging diagnostic tools in development, it is important to keep yourself informed about new opportunities for your patients. Make sure your healthcare institution possesses the up-to-date vision on preventative approaches to age-related diseases.